|
1
|
Berke G: The binding and lysis of target
cells by cytotoxic lymphocytes: Molecular and cellular aspects.
Annu Rev Immunol. 12:735–773. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Salih HR, Rammensee H-G and Steinle A:
Cutting edge: Down-regulation of MICA on human tumors by
proteolytic shedding. J Immunol. 169:4098–4102. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dunn GP, Old LJ and Schreiber RD: The
three Es of cancer immunoediting. Annu Rev Immunol. 22:329–360.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Robertson MJ, Soiffer RJ, Wolf SF, Manley
TJ, Donahue C, Young D, Herrmann SH and Ritz J: Response of human
natural killer (NK) cells to NK cell stimulatory factor (NKSF):
Cytolytic activity and proliferation of NK cells are differentially
regulated by NKSF. J Exp Med. 175:779–788. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhu L, Zhao Z, Wei Y, Marcotte W Jr,
Wagner TE and Yu X: An IL-12/Shh-C domain fusion protein-based
IL-12 autocrine loop for sustained natural killer cell activation.
Int J Oncol. 41:661–669. 2012.PubMed/NCBI
|
|
6
|
Brunda MJ, Luistro L, Warrier RR, Wright
RB, Hubbard BR, Murphy M, Wolf SF and Gately MK: Antitumor and
antimetastatic activity of interleukin 12 against murine tumors. J
Exp Med. 178:1223–1230. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Voest EE, Kenyon BM, OReilly MS, Truitt G,
DAmato RJ and Folkman J: Inhibition of angiogenesis in vivo by
interleukin 12. J Natl Cancer Inst. 87:581–586. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tietje A, Li J, Yu X and Wei Y:
MULT1E/mIL-12: A novel bifunctional protein for natural killer cell
activation. Gene Ther. 21:468–475. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Schoenhaut DS, Chua AO, Wolitzky AG, Quinn
PM, Dwyer CM, McComas W, Familletti PC, Gately MK and Gubler U:
Cloning and expression of murine IL-12. J Immunol. 148:3433–3440.
1992.PubMed/NCBI
|
|
10
|
Halenius A, Gerke C and Hengel H:
Classical and non-classical MHC I molecule manipulation by human
cytomegalovirus: So many targets-but how many arrows in the quiver?
Cell Mol Immunol. 12:139–153. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Groh V, Rhinehart R, Secrist H, Bauer S,
Grabstein KH and Spies T: Broad tumor-associated expression and
recognition by tumor-derived gamma delta T cells of MICA and MICB.
Proc Natl Acad Sci USA. 96:6879–6884. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Baltz KM, Krusch M, Baessler T, Schmiedel
BJ, Bringmann A, Brossart P and Salih HR: Neutralization of
tumor-derived soluble glucocorticoid-induced TNFR-related protein
ligand increases NK cell anti-tumor reactivity. Blood.
112:3735–3743. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu C, Yu S, Zinn K, Wang J, Zhang L, Jia
Y, Kappes JC, Barnes S, Kimberly RP, Grizzle WE, et al: Murine
mammary carcinoma exosomes promote tumor growth by suppression of
NK cell function. J Immunol. 176:1375–1385. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Buggins AG, Milojkovic D, Arno MJ, Lea NC,
Mufti GJ, Thomas NS and Hirst WJ: Microenvironment produced by
acute myeloid leukemia cells prevents T cell activation and
proliferation by inhibition of NF-kappaB, c-Myc, and pRb pathways.
J Immunol. 167:6021–6030. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Urosevic M and Dummer R: HLA-G and IL-10
expression in human cancer-different stories with the same message.
Semin Cancer Biol. 13:337–342. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Maki G, Klingemann HG, Martinson JA and
Tam YK: Factors regulating the cytotoxic activity of the human
natural killer cell line, NK-92. J Hematother Stem Cell Res.
10:369–383. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jin L, Zeng X, Liu M, Deng Y and He N:
Current progress in gene delivery technology based on chemical
methods and nano-carriers. Theranostics. 4:240–255. 2014.
View Article : Google Scholar : PubMed/NCBI
|
